Usuku H, Takashio S, Yamamoto E, Yamada T, Egashira K, Morioka M, Nishi M, Komorita T, Oike F, Tabata N, Ishii M, Yamanaga K, Fujisue K, Sueta D, Arima Y, Araki S, Oda S, Misumi Y, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K. Prognostic Value of Right Ventricular Global Longitudinal Strain in Transthyretin Amyloid Cardiomyopathy Journal of Cardiology. Journal of Cardiology. 2022 (in press).

Liu R, Shinriki S, Maeshiro M, Hirayama M, Jono H, Yoshida R, Nakayama H, Matsui H. The Tumour Suppressor CYLD is Required for Clathrin-mediated Endocytosis of EGFR and Cetuximab-induced Apoptosis in Head and Neck Squamous Cell Carcinoma. Cancers 14(1) 173, 2022. doi: 10.3390/cancers14010173

Oike F, Usuku H, Yamamoto E, Yamada T, Egashira K, Morioka M, Nishi M, Komorita T, Hirakawa K, Tabata N, Yamanaga K, Fujisue K, Hanatani S, Sueta D, Arima Y, Araki S, Takashio S, Oda S, Misumi Y, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K. Prognostic Value of Left Atrial Strain in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy. ESC Heart Fail 8(6): 5316-5326, 2021. doi: 10.1002/ehf2.13621.

Takahashi S, Kanai A, Okuda H, Miyamoto R, Komata Y, Kawamura T, Matsui H, Inaba T, Takaori-Kondo A, Yokoyama A. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis. eLife 10: e65872, 2021. doi: 10.7554/eLife.65872.

Akter S, Migiyama Y, Tsutsuki H, Ono K, Hamasaki C, Zhang T, Miyao K, Toyomoto T, Yamamoto K, Islam W, Sakagami T, Matsui H, Yamaguchi Y, Sawa T. Development of potent antipseudomonal β-lactams by means of polycarboxylation of aminopenicillins. Microbiol Immunol 65(10): 449-461, 2021. doi: 10.1111/1348-0421.12930

Miyamoto R, Kanai A, Okuda H, Komata Y, Takahashi H, Matsui H, Inaba T, Yokoyama A. HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways. eLife 10: e64148, 2021. doi: 10.7554/eLife.64148.

Usuku H, Yamamoto E, Oike F, Yoshinouchi T, Imamura K, YoshidaK, Kanesaki D, Toma Y, Tomita A, Ogata Y, Matsumoto S, Iwayama Y, Sassa T, Tanaka S, Fukuyoshi Y, Matsumoto T, Tanaka E, Misumi I, Shono H, Nishigami K, Tsujita K, Matsui H. Current Awareness and Status of Venous Ultrasonography in Kumamoto Prefecture: A Report of the Kumamoto Cardiovascular Echocardiography Standardization Project. Circ Rep 3(8): 449-456, 2021. doi: 10.1253/circrep.CR-21-0028.

Yamamoto K, Najima Y, Iizuka H, Harada Y, Sadato D, Kanai A, Matsui H, Inamoto K, Mukae J, Shingai N, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K, Harada H, Doki N. Successful cord blood transplantation for idiopathic CD4+ lymphocytopenia. Acta Hematol 144(6): 698-705, 2021. doi: 10.1159/000516347.

Ishihara A, Yamauchi T, Ikeda K, Fukuyoshi Y, Yokoyama T, Yonemura Y, Uchiba M, Matsui H. Glycosylated ferritin as an improved marker for post-transfusion iron overload. Int J Hematol. 113(4): 537-546, 2021. doi: 10.1007/s12185-020-03056-9

Usuku H, Yamamoto E, Noguchi M, Komorita T, Takae M, Oike M, Yamanaga K, Iro M, Fujisue K, Sueta D, Kanazawa H, Araki S, Arima Y, Takashio S, Nakamura T, Suzuki S, Kawano H, Soejima H, Kaikita K, Matsushita K, Fukui T, Matsui H, Tsujita K. Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease. Int J Cardiol. 328: 152-157, 2021. doi: 10.1016/j.ijcard.2020.12.053.

Sato K, Misumi I, Nagano M, Arima R, Ehara S, Sakamoto T, Usuku H, Kaikita K, Tsujita K.A Coronary Artery-left Ventricular Fistula though the Sinusoid.Intern Med. 2021 1;60(23): 3755-3758

Misumi I, Sato K, Nagano M, Obata M, Urata J, Usuku H, Kaikita K, Tsujita K.Left ventricular apical thrombus mimicking hypertrabeculation.Intern Med. 2021 15; 60(14)2245-2250

Egashira K, Sueta D, Tomiguchi M, Kidoh M, Oda S, Usuku H, Hidaka K, Goto-Yamaguchi R, Sueta A, Komorita T, Takae M, Oike F, Fujisue K, Yamamoto E, Hanatani S, Takashio S, Arima Y, Araki S, Kaikita K, Matsushita K,Yamamoto Y, Hirai T, Tsujita K.Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity.Int J Cardiol Heart Vasc 2021 May 18; 34:100797

Nakanishi N, Kaikita K, Ishii M, Kuyama N, Tabata N, Ito M, Yamanaga K, Fujisue K, Hoshiyama T, Kanazawa H, Hanatani S, Sueta D, Takashio S, Arima Y, Araki S, Usuku H, Nakamura T, Suzuki S, Yamamoto E,Soejima H, Matsushita K, Tsujita K.Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.Int J Cardiol. 2021 Feb 15;325:121-126

Nishihara T, Tokitsu T, Sueta D, Oike F, Takae M, Fujisue K, Usuku H, Ito M, Kanazawa H, Araki S, Arima Y, Takashio S, Nakamura T, Sakamoto K, Suzuki S, Kaikita K, Yamamoto E, Tsujita K.Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction.J Card Fail. 2021 Jan;27(1):57-66

Takashio　S, Yamada T, Nishi M, Morioka M, Fujiyama A, Nakashima N, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Ueda M, Matsushita K, Tsujita K.Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy.J Cardiol. 2021 Oct 29,S0914-5087(21)00278-1

Nishihara T, Yamamoto E, Sueta D, Fujisue K, Usuku H, Oike F, Takae M, Tabata N, Ito M, Yamanaga K, Kanazawa H, Arima Y, Araki S, Takashio S, Nakamura T, Suzuki S, Sakamoto K, Izumiya Y, Kaikita K, Tsujita K.Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.J Am Heart Assoc. 2021 Apr 6;10(7):e016765

Kanazawa H, Kaikita K, Ito M, Kawahara Y, Hoshiyama T, Kanemaru Y, Kiyama T, Iwashita S, Tabata N, Yamanaga K, Fujisue K, Sueta D, Takashio S, Arima Y, Araki S, Usuku H, Nakamura T, Izumiya Y, Sakamoro K, Suzuki S, Yamamoto E, Soejima H, Matsushita K, Tsujita K.Improvement of Vascular Endotherial Function Reflects Nonrecurrence After Catheter Ablation for Atrial Fibrillation.J Am Heart Assoc. 2021 Sep 7; 10(17):e021551

Takae M, Fujisue K, Yamamoto E, Egashira K, Komorita T, Oike F, Nishihara T, Yamamoto M, Hirakawa K, Tabata N, Tokitsu T, Yamanaga K, Sueta D, Hanatani S, Nakamura T, Usuku H, Araki S, Arima Y, Takashio S, Suzuki S, Kaikita K, Matsushita K, Tsujita K. Prognostic significance of Liver stiffness assessed by fibrosis-4 index in patients with heart failure.ESC hear failure 2021 Oct;8(5):3809-3821

Nakanishi N, Kaikita K, Ishii M, Kuyama N, Tabata N, Ito M, Yamanaga K, Fujisue K, Hoshiyama T, Kanazawa H, Hanatani S, Sueta D, Takashio S, Arima Y, Araki S, Usuku H, Nakamura T, Suzuki S, Yamamoto E, Soejima H, Katsushita K, Tsujita K. Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.Thromb Res. 2021 Apr;200:141-148

Fujisue K, Yamamoto E, Sueta D, Arima Y, Hirakawa K, Tabata N, Ishi M, Ito M, Yamanaga K, Hanatani S, Hoshiyama T, Kanazawa H, Takashio S, Araki S, Usuku H, Nakamura T, Soejima H, Kaikita K, Kawano H, Matsushita K, Tsujita K. A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers.J Atheroscler Thromb. 2021 Sep 28. Doi: 10.5551/jat.63044

Yamana K, Inoue J, Yoshida R, Sakata J, Nakashima H, Arita H, Kawaguchi S, Gohara S, Nagao Y, Takeshita H, Maeshiro M, Liu R, Matsuoka Y, Hirayama M, Kawahara K, Nagata M, Hirosue A, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis. J. Extracell. Vesicles. 10(14):e12169, 2021.